The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cisatracurium Besylate Market Research Report 2025
Synopsis
Cisatracurium besylate is the latest generation of muscle relaxant. Compared with the major clinical muscle relaxants, this product has the characteristics of metabolism through non-hepatic and non-renal pathways and cardiovascular stability.Atracurium is mainly used in general anesthesia, and can be widely used in endotracheal intubation, liver and kidney dysfunction, cardiovascular surgery and elderly and pediatric patients.Since the drug was first marketed in the UK in 1996, it has gradually replaced vecuronium bromide and atracurium in foreign countries and become the mainstream of clinical muscle relaxants.
The global Cisatracurium Besylate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cisatracurium Besylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cisatracurium Besylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cisatracurium Besylate include GSK, Aspen Pharmacare, AbbVie, Abbott, Pfizer, Mylan Pharmaceuticals, Fresenius Kabi, Omega Laboratories Ltd and Somerset Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cisatracurium Besylate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cisatracurium Besylate.
Report Scope
The Cisatracurium Besylate market size, estimations, and forecasts are provided in terms of sales volume (Litre) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cisatracurium Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cisatracurium Besylate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Aspen Pharmacare
AbbVie
Abbott
Pfizer
Mylan Pharmaceuticals
Fresenius Kabi
Omega Laboratories Ltd
Somerset Therapeutics
Jiangsu Hengrui Medicine
Shanghai Pharmaceuticals Holding
Zhejiang Xianju
Segment by Type
Solution
Injection
Segment by Application
General Anesthesia
Endotracheal Intubation
Liver And Kidney Dysfunction
Cardiovascular Surgery
Old Families
Pediatric
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cisatracurium Besylate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cisatracurium Besylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Cisatracurium besylate is the latest generation of muscle relaxant. Compared with the major clinical muscle relaxants, this product has the characteristics of metabolism through non-hepatic and non-renal pathways and cardiovascular stability.Atracurium is mainly used in general anesthesia, and can be widely used in endotracheal intubation, liver and kidney dysfunction, cardiovascular surgery and elderly and pediatric patients.Since the drug was first marketed in the UK in 1996, it has gradually replaced vecuronium bromide and atracurium in foreign countries and become the mainstream of clinical muscle relaxants.
The global Cisatracurium Besylate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cisatracurium Besylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cisatracurium Besylate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cisatracurium Besylate include GSK, Aspen Pharmacare, AbbVie, Abbott, Pfizer, Mylan Pharmaceuticals, Fresenius Kabi, Omega Laboratories Ltd and Somerset Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cisatracurium Besylate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cisatracurium Besylate.
Report Scope
The Cisatracurium Besylate market size, estimations, and forecasts are provided in terms of sales volume (Litre) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cisatracurium Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cisatracurium Besylate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Aspen Pharmacare
AbbVie
Abbott
Pfizer
Mylan Pharmaceuticals
Fresenius Kabi
Omega Laboratories Ltd
Somerset Therapeutics
Jiangsu Hengrui Medicine
Shanghai Pharmaceuticals Holding
Zhejiang Xianju
Segment by Type
Solution
Injection
Segment by Application
General Anesthesia
Endotracheal Intubation
Liver And Kidney Dysfunction
Cardiovascular Surgery
Old Families
Pediatric
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cisatracurium Besylate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cisatracurium Besylate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Cisatracurium Besylate Market Overview
1.1 Product Overview and Scope of Cisatracurium Besylate
1.2 Cisatracurium Besylate Segment by Type
1.2.1 Global Cisatracurium Besylate Market Value Comparison by Type (2024-2030)
1.2.2 Solution
1.2.3 Injection
1.3 Cisatracurium Besylate Segment by Application
1.3.1 Global Cisatracurium Besylate Market Value by Application: (2024-2030)
1.3.2 General Anesthesia
1.3.3 Endotracheal Intubation
1.3.4 Liver And Kidney Dysfunction
1.3.5 Cardiovascular Surgery
1.3.6 Old Families
1.3.7 Pediatric
1.3.8 Other
1.4 Global Cisatracurium Besylate Market Size Estimates and Forecasts
1.4.1 Global Cisatracurium Besylate Revenue 2019-2030
1.4.2 Global Cisatracurium Besylate Sales 2019-2030
1.4.3 Global Cisatracurium Besylate Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cisatracurium Besylate Market Competition by Manufacturers
2.1 Global Cisatracurium Besylate Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cisatracurium Besylate Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cisatracurium Besylate Average Price by Manufacturers (2019-2024)
2.4 Global Cisatracurium Besylate Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cisatracurium Besylate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cisatracurium Besylate, Product Type & Application
2.7 Cisatracurium Besylate Market Competitive Situation and Trends
2.7.1 Cisatracurium Besylate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cisatracurium Besylate Players Market Share by Revenue
2.7.3 Global Cisatracurium Besylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cisatracurium Besylate Retrospective Market Scenario by Region
3.1 Global Cisatracurium Besylate Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cisatracurium Besylate Global Cisatracurium Besylate Sales by Region: 2019-2030
3.2.1 Global Cisatracurium Besylate Sales by Region: 2019-2024
3.2.2 Global Cisatracurium Besylate Sales by Region: 2025-2030
3.3 Global Cisatracurium Besylate Global Cisatracurium Besylate Revenue by Region: 2019-2030
3.3.1 Global Cisatracurium Besylate Revenue by Region: 2019-2024
3.3.2 Global Cisatracurium Besylate Revenue by Region: 2025-2030
3.4 North America Cisatracurium Besylate Market Facts & Figures by Country
3.4.1 North America Cisatracurium Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cisatracurium Besylate Sales by Country (2019-2030)
3.4.3 North America Cisatracurium Besylate Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cisatracurium Besylate Market Facts & Figures by Country
3.5.1 Europe Cisatracurium Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cisatracurium Besylate Sales by Country (2019-2030)
3.5.3 Europe Cisatracurium Besylate Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cisatracurium Besylate Market Facts & Figures by Country
3.6.1 Asia Pacific Cisatracurium Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cisatracurium Besylate Sales by Country (2019-2030)
3.6.3 Asia Pacific Cisatracurium Besylate Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cisatracurium Besylate Market Facts & Figures by Country
3.7.1 Latin America Cisatracurium Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cisatracurium Besylate Sales by Country (2019-2030)
3.7.3 Latin America Cisatracurium Besylate Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cisatracurium Besylate Market Facts & Figures by Country
3.8.1 Middle East and Africa Cisatracurium Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cisatracurium Besylate Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cisatracurium Besylate Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cisatracurium Besylate Sales by Type (2019-2030)
4.1.1 Global Cisatracurium Besylate Sales by Type (2019-2024)
4.1.2 Global Cisatracurium Besylate Sales by Type (2025-2030)
4.1.3 Global Cisatracurium Besylate Sales Market Share by Type (2019-2030)
4.2 Global Cisatracurium Besylate Revenue by Type (2019-2030)
4.2.1 Global Cisatracurium Besylate Revenue by Type (2019-2024)
4.2.2 Global Cisatracurium Besylate Revenue by Type (2025-2030)
4.2.3 Global Cisatracurium Besylate Revenue Market Share by Type (2019-2030)
4.3 Global Cisatracurium Besylate Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cisatracurium Besylate Sales by Application (2019-2030)
5.1.1 Global Cisatracurium Besylate Sales by Application (2019-2024)
5.1.2 Global Cisatracurium Besylate Sales by Application (2025-2030)
5.1.3 Global Cisatracurium Besylate Sales Market Share by Application (2019-2030)
5.2 Global Cisatracurium Besylate Revenue by Application (2019-2030)
5.2.1 Global Cisatracurium Besylate Revenue by Application (2019-2024)
5.2.2 Global Cisatracurium Besylate Revenue by Application (2025-2030)
5.2.3 Global Cisatracurium Besylate Revenue Market Share by Application (2019-2030)
5.3 Global Cisatracurium Besylate Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Cisatracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Cisatracurium Besylate Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Aspen Pharmacare
6.2.1 Aspen Pharmacare Corporation Information
6.2.2 Aspen Pharmacare Description and Business Overview
6.2.3 Aspen Pharmacare Cisatracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Aspen Pharmacare Cisatracurium Besylate Product Portfolio
6.2.5 Aspen Pharmacare Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Corporation Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Cisatracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AbbVie Cisatracurium Besylate Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Abbott
6.4.1 Abbott Corporation Information
6.4.2 Abbott Description and Business Overview
6.4.3 Abbott Cisatracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Cisatracurium Besylate Product Portfolio
6.4.5 Abbott Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Cisatracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Cisatracurium Besylate Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Mylan Pharmaceuticals
6.6.1 Mylan Pharmaceuticals Corporation Information
6.6.2 Mylan Pharmaceuticals Description and Business Overview
6.6.3 Mylan Pharmaceuticals Cisatracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mylan Pharmaceuticals Cisatracurium Besylate Product Portfolio
6.6.5 Mylan Pharmaceuticals Recent Developments/Updates
6.7 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Cisatracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fresenius Kabi Cisatracurium Besylate Product Portfolio
6.7.5 Fresenius Kabi Recent Developments/Updates
6.8 Omega Laboratories Ltd
6.8.1 Omega Laboratories Ltd Corporation Information
6.8.2 Omega Laboratories Ltd Description and Business Overview
6.8.3 Omega Laboratories Ltd Cisatracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Omega Laboratories Ltd Cisatracurium Besylate Product Portfolio
6.8.5 Omega Laboratories Ltd Recent Developments/Updates
6.9 Somerset Therapeutics
6.9.1 Somerset Therapeutics Corporation Information
6.9.2 Somerset Therapeutics Description and Business Overview
6.9.3 Somerset Therapeutics Cisatracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Somerset Therapeutics Cisatracurium Besylate Product Portfolio
6.9.5 Somerset Therapeutics Recent Developments/Updates
6.10 Jiangsu Hengrui Medicine
6.10.1 Jiangsu Hengrui Medicine Corporation Information
6.10.2 Jiangsu Hengrui Medicine Description and Business Overview
6.10.3 Jiangsu Hengrui Medicine Cisatracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jiangsu Hengrui Medicine Cisatracurium Besylate Product Portfolio
6.10.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.11 Shanghai Pharmaceuticals Holding
6.11.1 Shanghai Pharmaceuticals Holding Corporation Information
6.11.2 Shanghai Pharmaceuticals Holding Cisatracurium Besylate Description and Business Overview
6.11.3 Shanghai Pharmaceuticals Holding Cisatracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shanghai Pharmaceuticals Holding Cisatracurium Besylate Product Portfolio
6.11.5 Shanghai Pharmaceuticals Holding Recent Developments/Updates
6.12 Zhejiang Xianju
6.12.1 Zhejiang Xianju Corporation Information
6.12.2 Zhejiang Xianju Cisatracurium Besylate Description and Business Overview
6.12.3 Zhejiang Xianju Cisatracurium Besylate Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zhejiang Xianju Cisatracurium Besylate Product Portfolio
6.12.5 Zhejiang Xianju Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cisatracurium Besylate Industry Chain Analysis
7.2 Cisatracurium Besylate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cisatracurium Besylate Production Mode & Process
7.4 Cisatracurium Besylate Sales and Marketing
7.4.1 Cisatracurium Besylate Sales Channels
7.4.2 Cisatracurium Besylate Distributors
7.5 Cisatracurium Besylate Customers
8 Cisatracurium Besylate Market Dynamics
8.1 Cisatracurium Besylate Industry Trends
8.2 Cisatracurium Besylate Market Drivers
8.3 Cisatracurium Besylate Market Challenges
8.4 Cisatracurium Besylate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Cisatracurium Besylate Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Cisatracurium Besylate Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Cisatracurium Besylate Market Competitive Situation by Manufacturers in 2023
Table 4. Global Cisatracurium Besylate Sales (Litre) of Key Manufacturers (2019-2024)
Table 5. Global Cisatracurium Besylate Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Cisatracurium Besylate Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Cisatracurium Besylate Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Cisatracurium Besylate Average Price (US$/ML) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Cisatracurium Besylate, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cisatracurium Besylate, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cisatracurium Besylate, Product Type & Application
Table 12. Global Key Manufacturers of Cisatracurium Besylate, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cisatracurium Besylate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cisatracurium Besylate as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cisatracurium Besylate Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Cisatracurium Besylate Sales by Region (2019-2024) & (Litre)
Table 18. Global Cisatracurium Besylate Sales Market Share by Region (2019-2024)
Table 19. Global Cisatracurium Besylate Sales by Region (2025-2030) & (Litre)
Table 20. Global Cisatracurium Besylate Sales Market Share by Region (2025-2030)
Table 21. Global Cisatracurium Besylate Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Cisatracurium Besylate Revenue Market Share by Region (2019-2024)
Table 23. Global Cisatracurium Besylate Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Cisatracurium Besylate Revenue Market Share by Region (2025-2030)
Table 25. North America Cisatracurium Besylate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Cisatracurium Besylate Sales by Country (2019-2024) & (Litre)
Table 27. North America Cisatracurium Besylate Sales by Country (2025-2030) & (Litre)
Table 28. North America Cisatracurium Besylate Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Cisatracurium Besylate Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Cisatracurium Besylate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Cisatracurium Besylate Sales by Country (2019-2024) & (Litre)
Table 32. Europe Cisatracurium Besylate Sales by Country (2025-2030) & (Litre)
Table 33. Europe Cisatracurium Besylate Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Cisatracurium Besylate Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Cisatracurium Besylate Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Cisatracurium Besylate Sales by Region (2019-2024) & (Litre)
Table 37. Asia Pacific Cisatracurium Besylate Sales by Region (2025-2030) & (Litre)
Table 38. Asia Pacific Cisatracurium Besylate Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Cisatracurium Besylate Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Cisatracurium Besylate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Cisatracurium Besylate Sales by Country (2019-2024) & (Litre)
Table 42. Latin America Cisatracurium Besylate Sales by Country (2025-2030) & (Litre)
Table 43. Latin America Cisatracurium Besylate Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Cisatracurium Besylate Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Cisatracurium Besylate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Cisatracurium Besylate Sales by Country (2019-2024) & (Litre)
Table 47. Middle East & Africa Cisatracurium Besylate Sales by Country (2025-2030) & (Litre)
Table 48. Middle East & Africa Cisatracurium Besylate Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Cisatracurium Besylate Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Cisatracurium Besylate Sales (Litre) by Type (2019-2024)
Table 51. Global Cisatracurium Besylate Sales (Litre) by Type (2025-2030)
Table 52. Global Cisatracurium Besylate Sales Market Share by Type (2019-2024)
Table 53. Global Cisatracurium Besylate Sales Market Share by Type (2025-2030)
Table 54. Global Cisatracurium Besylate Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Cisatracurium Besylate Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Cisatracurium Besylate Revenue Market Share by Type (2019-2024)
Table 57. Global Cisatracurium Besylate Revenue Market Share by Type (2025-2030)
Table 58. Global Cisatracurium Besylate Price (US$/ML) by Type (2019-2024)
Table 59. Global Cisatracurium Besylate Price (US$/ML) by Type (2025-2030)
Table 60. Global Cisatracurium Besylate Sales (Litre) by Application (2019-2024)
Table 61. Global Cisatracurium Besylate Sales (Litre) by Application (2025-2030)
Table 62. Global Cisatracurium Besylate Sales Market Share by Application (2019-2024)
Table 63. Global Cisatracurium Besylate Sales Market Share by Application (2025-2030)
Table 64. Global Cisatracurium Besylate Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Cisatracurium Besylate Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Cisatracurium Besylate Revenue Market Share by Application (2019-2024)
Table 67. Global Cisatracurium Besylate Revenue Market Share by Application (2025-2030)
Table 68. Global Cisatracurium Besylate Price (US$/ML) by Application (2019-2024)
Table 69. Global Cisatracurium Besylate Price (US$/ML) by Application (2025-2030)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 73. GSK Cisatracurium Besylate Product
Table 74. GSK Recent Developments/Updates
Table 75. Aspen Pharmacare Corporation Information
Table 76. Aspen Pharmacare Description and Business Overview
Table 77. Aspen Pharmacare Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 78. Aspen Pharmacare Cisatracurium Besylate Product
Table 79. Aspen Pharmacare Recent Developments/Updates
Table 80. AbbVie Corporation Information
Table 81. AbbVie Description and Business Overview
Table 82. AbbVie Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 83. AbbVie Cisatracurium Besylate Product
Table 84. AbbVie Recent Developments/Updates
Table 85. Abbott Corporation Information
Table 86. Abbott Description and Business Overview
Table 87. Abbott Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 88. Abbott Cisatracurium Besylate Product
Table 89. Abbott Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 93. Pfizer Cisatracurium Besylate Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Mylan Pharmaceuticals Corporation Information
Table 96. Mylan Pharmaceuticals Description and Business Overview
Table 97. Mylan Pharmaceuticals Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 98. Mylan Pharmaceuticals Cisatracurium Besylate Product
Table 99. Mylan Pharmaceuticals Recent Developments/Updates
Table 100. Fresenius Kabi Corporation Information
Table 101. Fresenius Kabi Description and Business Overview
Table 102. Fresenius Kabi Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 103. Fresenius Kabi Cisatracurium Besylate Product
Table 104. Fresenius Kabi Recent Developments/Updates
Table 105. Omega Laboratories Ltd Corporation Information
Table 106. Omega Laboratories Ltd Description and Business Overview
Table 107. Omega Laboratories Ltd Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 108. Omega Laboratories Ltd Cisatracurium Besylate Product
Table 109. Omega Laboratories Ltd Recent Developments/Updates
Table 110. Somerset Therapeutics Corporation Information
Table 111. Somerset Therapeutics Description and Business Overview
Table 112. Somerset Therapeutics Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 113. Somerset Therapeutics Cisatracurium Besylate Product
Table 114. Somerset Therapeutics Recent Developments/Updates
Table 115. Jiangsu Hengrui Medicine Corporation Information
Table 116. Jiangsu Hengrui Medicine Description and Business Overview
Table 117. Jiangsu Hengrui Medicine Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 118. Jiangsu Hengrui Medicine Cisatracurium Besylate Product
Table 119. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 120. Shanghai Pharmaceuticals Holding Corporation Information
Table 121. Shanghai Pharmaceuticals Holding Description and Business Overview
Table 122. Shanghai Pharmaceuticals Holding Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 123. Shanghai Pharmaceuticals Holding Cisatracurium Besylate Product
Table 124. Shanghai Pharmaceuticals Holding Recent Developments/Updates
Table 125. Zhejiang Xianju Corporation Information
Table 126. Zhejiang Xianju Description and Business Overview
Table 127. Zhejiang Xianju Cisatracurium Besylate Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2019-2024)
Table 128. Zhejiang Xianju Cisatracurium Besylate Product
Table 129. Zhejiang Xianju Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Cisatracurium Besylate Distributors List
Table 133. Cisatracurium Besylate Customers List
Table 134. Cisatracurium Besylate Market Trends
Table 135. Cisatracurium Besylate Market Drivers
Table 136. Cisatracurium Besylate Market Challenges
Table 137. Cisatracurium Besylate Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cisatracurium Besylate
Figure 2. Global Cisatracurium Besylate Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Cisatracurium Besylate Market Share by Type in 2023 & 2030
Figure 4. Solution Product Picture
Figure 5. Injection Product Picture
Figure 6. Global Cisatracurium Besylate Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Cisatracurium Besylate Market Share by Application in 2023 & 2030
Figure 8. General Anesthesia
Figure 9. Endotracheal Intubation
Figure 10. Liver And Kidney Dysfunction
Figure 11. Cardiovascular Surgery
Figure 12. Old Families
Figure 13. Pediatric
Figure 14. Other
Figure 15. Global Cisatracurium Besylate Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Cisatracurium Besylate Market Size (2019-2030) & (US$ Million)
Figure 17. Global Cisatracurium Besylate Sales (2019-2030) & (Litre)
Figure 18. Global Cisatracurium Besylate Average Price (US$/ML) & (2019-2030)
Figure 19. Cisatracurium Besylate Report Years Considered
Figure 20. Cisatracurium Besylate Sales Share by Manufacturers in 2023
Figure 21. Global Cisatracurium Besylate Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Cisatracurium Besylate Players: Market Share by Revenue in 2023
Figure 23. Cisatracurium Besylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Cisatracurium Besylate Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Cisatracurium Besylate Sales Market Share by Country (2019-2030)
Figure 26. North America Cisatracurium Besylate Revenue Market Share by Country (2019-2030)
Figure 27. U.S. Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Cisatracurium Besylate Sales Market Share by Country (2019-2030)
Figure 30. Europe Cisatracurium Besylate Revenue Market Share by Country (2019-2030)
Figure 31. Germany Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Cisatracurium Besylate Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Cisatracurium Besylate Revenue Market Share by Region (2019-2030)
Figure 38. China Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Taiwan Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Philippines Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Latin America Cisatracurium Besylate Sales Market Share by Country (2019-2030)
Figure 49. Latin America Cisatracurium Besylate Revenue Market Share by Country (2019-2030)
Figure 50. Mexico Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Brazil Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Argentina Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Cisatracurium Besylate Sales Market Share by Country (2019-2030)
Figure 54. Middle East & Africa Cisatracurium Besylate Revenue Market Share by Country (2019-2030)
Figure 55. Turkey Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. UAE Cisatracurium Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Global Sales Market Share of Cisatracurium Besylate by Type (2019-2030)
Figure 59. Global Revenue Market Share of Cisatracurium Besylate by Type (2019-2030)
Figure 60. Global Cisatracurium Besylate Price (US$/ML) by Type (2019-2030)
Figure 61. Global Sales Market Share of Cisatracurium Besylate by Application (2019-2030)
Figure 62. Global Revenue Market Share of Cisatracurium Besylate by Application (2019-2030)
Figure 63. Global Cisatracurium Besylate Price (US$/ML) by Application (2019-2030)
Figure 64. Cisatracurium Besylate Value Chain
Figure 65. Cisatracurium Besylate Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
